Evidence map›Paper›PMID 37864267›Full record

Observational studyAddiction science & clinical practice2023

GHB: a life-threatening drug complications and outcome of GHB detoxification treatment-an observational clinical study.

Peter Neu, Heidi Danker-Hopfe, Robert Fisher, Felicitas Ehlen

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Addiction science & clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Peter NeuJüdisches Krankenhaus Berlin-Clinic for Psychiatry and Psychotherapy, Heinz-Galinski-Str. 1, 13347, Berlin, Germany. peter.neu@jkb-online.de.ORCID 0000-0002-6616-6594
Heidi Danker-HopfeCompetence Center for Sleep Medicine, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany.
Robert FisherStepney and Wapping CMHT, Queen Mary University, Wolfson Institute for Preventive Medicine, 68 Glasshouse Fields, London, E1W 3AB, UK.
Felicitas EhlenJüdisches Krankenhaus Berlin-Clinic for Psychiatry and Psychotherapy, Heinz-Galinski-Str. 1, 13347, Berlin, Germany.
Jüdisches Krankenhaus Berlin · DEFranklin University · USQueen Mary University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGHB (gammahydroxybutyrate) and its precursors are popular recreational drugs due to their sedative, anxiolytic and sexually stimulating effects. Their use has been steadily increasing in recent years. The detoxification process is complex and prone to high rates of complications while little is known about the pathophysiology. This study aims to elucidate the characteristics of GHB-addicted patients and to evaluate the risks and complications of GHB withdrawal treatment.

methodsThis observational study describes prospectively the socioeconomic status, clinical history and course of inpatient detoxification treatment of a group of 39 patients suffering from GHB substance use disorder. Detoxification treatment took place in a highly specialized psychiatric inpatient unit for substance use disorders.

resultsGHB patients were characterised by being young, well-educated and by living alone. More than 50% of the patients had no regular income. The patients were male and female in equal numbers. Detoxification treatment was complicated, with high rates of delirium (30.8%) and high need for intensive care (20.5%).

conclusionsIn our sample, GHB users were young, well-educated people and male and female in equal number. Detoxification proved to be dangerous for GHB-addicted patients. The presence of delirium and the need for transfer to an intensive care unit during detoxification treatment was extraordinarily high, even with appropriate clinical treatment. The reasons for this remain unknown. Therefore an intensive care unit should be available for GHB detoxification treatment. Further studies are needed to evaluate the options for prophylactic treatment of delirium during detoxification.

Indexed as

DeliriumSodium OxybateSubstance-Related DisordersSubstance Withdrawal SyndromeFemaleHumansInpatientsMaleSodium OxybateDeliriumDetoxificationGHBIntensive care unit

Identifiers

PMID37864267
PMCPMC10590033
OpenAlexW4387840900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.